Encision (OTCMKTS:ECIA) (OTCMKTS:ECIA) is a medical device company specializing in the design, development and manufacture of advanced electrosurgical instruments aimed at improving safety and outcomes in minimally invasive surgery. The company’s proprietary technology is engineered to control and confine radio-frequency energy at the surgical site, reducing the risk of inadvertent thermal injury to surrounding tissue. Encision’s product portfolio includes insulated laparoscopic instruments, vessel sealers and accessory devices that integrate seamlessly into existing surgical workflows.
At the core of Encision’s offerings is a line of patented electrode and instrument designs that minimize stray electromagnetic fields (EMF) during electrosurgical procedures. These instruments are FDA-cleared and are commonly used by surgeons in general, gynecological, urological and bariatric procedures. The company also provides technical support, clinician training programs and custom instrument development services to hospitals, surgery centers and integrated delivery networks.
Encision markets its products primarily in the United States, serving a broad network of healthcare providers, and maintains strategic distribution partnerships in Europe, Asia and Latin America. The company’s international footprint continues to expand through collaborations with local distributors and by participating in surgical trade shows and clinical conferences worldwide. Support infrastructure includes a dedicated customer service team and field representatives who offer in-service training and clinical case support.
Founded in the late 1990s under the name Or-Dyne Surgical Instruments, the business rebranded as Encision in 2005 to reflect its focus on enclosed energy systems. Today, Encision is led by President and Chief Executive Officer Andrew I. Pollack, who brings more than two decades of experience in medical device innovation and commercialization. Under his leadership, the company has secured multiple patents and regulatory clearances, reinforcing its commitment to advancing surgical safety technology.
